S K Spangler
About
S K Spangler is a scholar working on Epidemiology, Pharmacology and Clinical Biochemistry.
According to data from OpenAlex, S K Spangler has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 23 papers in Pharmacology and 20 papers in Clinical Biochemistry. Recurrent topics in S K Spangler's work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Bacterial Identification and Susceptibility Testing (20 papers) and Antibiotic Resistance in Bacteria (19 papers). S K Spangler is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (23 papers), Bacterial Identification and Susceptibility Testing (20 papers) and Antibiotic Resistance in Bacteria (19 papers). S K Spangler collaborates with scholars based in United States and France. S K Spangler's co-authors include Peter C. Appelbaum, Michael R. Jacobs, M R Jacobs, Lois M. Ednie, Glenn A. Pankuch, Shigeru Yamabe, A. Philippon, Gengrong Lin, Ludwig Gutmann and M Visalli and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.
In The Last Decade
S K Spangler
47 papers receiving 1.3k citations
Peers
S K Spangler
Iciar Rodríguez-Avial Spain
Ronald N. Jones United States
Michael Kresken Germany
Kimberly A. Nichol Canada
Carmen Betriú Spain
Kim Nichol Canada
Matthew G. Stilwell United States
Jeffrey J. Zuravleff United States
K. Dornbusch Sweden
T.G. Winstanley United Kingdom
Citations per year, relative to S K Spangler S K Spangler (= 1×)
peers
Iciar Rodríguez-Avial
Countries citing papers authored by S K Spangler
Since
Specialization
Citations
This map shows the geographic impact of S K Spangler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S K Spangler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S K Spangler more than expected).
Fields of papers citing papers by S K Spangler
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by S K Spangler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S K Spangler. The network helps show where S K Spangler may publish in the future.
Co-authorship network of co-authors of S K Spangler
This figure shows the co-authorship network connecting the top 25 collaborators of S K Spangler. A scholar is included among the top collaborators of S K Spangler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S K Spangler. S K Spangler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Spangler, S K, Gengrong Lin, Michael R. Jacobs, & Peter C. Appelbaum. (1998). Postantibiotic Effect and Postantibiotic Sub-MIC Effect of Levofloxacin Compared to Those of Ofloxacin, Ciprofloxacin, Erythromycin, Azithromycin, and Clarithromycin against 20 Pneumococci. Antimicrobial Agents and Chemotherapy. 42(5). 1253–1255.
2.
Spangler, S K, Michael R. Jacobs, & Peter C. Appelbaum. (1997). Time-kill study of the activity of trovafloxacin compared with ciprofloxacin, sparfloxacin, metronidazole, cefoxitin, piperacillin and piperacillin/tazobactam against six anaerobes. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 23–27.
3.
Ednie, Lois M., S K Spangler, Michael R. Jacobs, & Peter C. Appelbaum. (1997). Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole. Antimicrobial Agents and Chemotherapy. 41(5). 1037–1041.
4.
Spangler, S K, Michael R. Jacobs, & Peter C. Appelbaum. (1997). MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents. Antimicrobial Agents and Chemotherapy. 41(1). 148–155.
5.
Spangler, S K, Michael R. Jacobs, & Peter C. Appelbaum. (1996). Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci. Antimicrobial Agents and Chemotherapy. 40(2). 481–484.
6.
Appelbaum, Peter C., et al.. (1994). Comparison of the E-test and conventional agar dilution methods for susceptibility testing of gram-negative anaerobic rods. Diagnostic Microbiology and Infectious Disease. 18(1). 25–30.
7.
Appelbaum, Peter C., S K Spangler, Glenn A. Pankuch, et al.. (1994). Characterization of a β-lactamase from Clostridium clostridioforme. Journal of Antimicrobial Chemotherapy. 33(1). 33–40.
8.
Appelbaum, Peter C., S K Spangler, & Michael R. Jacobs. (1993). Susceptibility of 539 Gram-positive and Gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam. Journal of Antimicrobial Chemotherapy. 32(2). 223–231.
9.
Spangler, S K, Michael R. Jacobs, Glenn A. Pankuch, & Peter C. Appelbaum. (1993). Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829. Journal of Antimicrobial Chemotherapy. 31(2). 273–280.
10.
Spangler, S K, Michael R. Jacobs, & Peter C. Appelbaum. (1993). Comparative activity of the new fluoroquinolone bay y3118 against 177 penicillin susceptible and resistant pneumococci. European Journal of Clinical Microbiology & Infectious Diseases. 12(12). 965–967.
11.
Jacobs, Michael R., S K Spangler, & Peter C. Appelbaum. (1992). Beta-lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents. European Journal of Clinical Microbiology & Infectious Diseases. 11(11). 1081–1093.
12.
Appelbaum, Peter C., S K Spangler, & Michael R. Jacobs. (1990). Evaluation of two methods for rapid testing for beta-lactamase production inBacteroides andFusobacterium. European Journal of Clinical Microbiology & Infectious Diseases. 9(1). 47–50.
13.
Jacobs, Michael R., S K Spangler, & Peter C. Appelbaum. (1990). Susceptibility ofBacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole. European Journal of Clinical Microbiology & Infectious Diseases. 9(6). 417–421.
14.
Jacobs, Michael R., S K Spangler, & Peter C. Appelbaum. (1990). β-Lactamase production, β-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres. Journal of Antimicrobial Chemotherapy. 26(3). 361–370.
15.
Remick, Daniel G., et al.. (1990). Intravascular plastic catheters potentiate tumor necrosis factor release and cardiac dysfunction secondary to infection.. PubMed. 46(6). 486–9.
16.
Appelbaum, Peter C., et al.. (1989). Susceptibility of penicillin-sensitive and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones. Journal of Antimicrobial Chemotherapy. 23(4). 509–516.
17.
Martin, Louis F., et al.. (1989). Vascular prosthetic infection with Experimental study of pathogenesis and therapy. Journal of Vascular Surgery. 9(3). 464–471.
18.
Appelbaum, Peter C., S K Spangler, & Melvin Strauss. (1988). Reduction of oral flora with ciprofloxacin in healthy volunteers. Journal of Antimicrobial Chemotherapy. 21(2). 243–249.
19.
Appelbaum, Peter C., et al.. (1988). Susceptibility of 310 Nonfermentative Gram-Negative Bacteria to Aztreonam, Carumonam, Ciprofloxacin, Ofloxacin and Fleroxacin. Chemotherapy. 34(1). 40–45.
20.
Appelbaum, Peter C., et al.. (1988). Survival of bacteria in Difco CultureSwab and Marion Culturette II transport systems. Journal of Clinical Microbiology. 26(1). 136–138.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Iciar Rodríguez-Avial Breakdown of academic impact, for papers by Ronald N. Jones Breakdown of academic impact, for papers by Michael Kresken Breakdown of academic impact, for papers by Kimberly A. Nichol Breakdown of academic impact, for papers by Carmen Betriú Breakdown of academic impact, for papers by Kim Nichol Breakdown of academic impact, for papers by Matthew G. Stilwell Breakdown of academic impact, for papers by Jeffrey J. Zuravleff Breakdown of academic impact, for papers by K. Dornbusch Breakdown of academic impact, for papers by T.G. Winstanley